Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin

This publication has 101 references indexed in Scilit:

• Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens
  The Journal of Molecular Diagnostics, 2011
• Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information
  Annals of Oncology, 2010
• Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
  New England Journal of Medicine, 2010
• When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology
  JNCI: Journal of the National Cancer Institute, 2010
• The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
  Genetics in Medicine, 2009
• Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
  Clinical Cancer Research, 2008
• Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
  New England Journal of Medicine, 2008
• A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
  BMC Cancer, 2007
• Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
  British Journal of Cancer, 1995
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
  BMJ, 1993